US5766891A
(en)
|
1994-12-19 |
1998-06-16 |
Sloan-Kettering Institute For Cancer Research |
Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
|
JP3441899B2
(ja)
*
|
1996-11-01 |
2003-09-02 |
理化学研究所 |
完全長cDNAライブラリーの作成方法
|
JP4447664B2
(ja)
|
1997-06-12 |
2010-04-07 |
スローン―ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
ワクシニアトポイソメラーゼにより触媒されるrna鎖に対するdna鎖の共有結合
|
JP2001512013A
(ja)
*
|
1997-08-01 |
2001-08-21 |
ジェンセット |
前立腺に発現される分泌タンパク質の5’est
|
WO1999006439A2
(en)
*
|
1997-08-01 |
1999-02-11 |
Genset |
5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
|
US6222029B1
(en)
*
|
1997-08-01 |
2001-04-24 |
Genset |
5′ ESTs for secreted proteins expressed in brain
|
PT1375514E
(pt)
*
|
1997-08-01 |
2006-10-31 |
Serono Genetics Inst Sa |
Ests 5' para proteinas secretadas expressas em varios tecidos
|
US7393663B2
(en)
|
1997-08-01 |
2008-07-01 |
Serono Genetics Institute S.A. |
Expressed sequence tags and encoded human proteins
|
ES2267192T3
(es)
*
|
1997-08-01 |
2007-03-01 |
Serono Genetics Institute S.A. |
Ests 5' para proteinas secretadas no especificas de tejido.
|
ES2359401T3
(es)
*
|
1997-08-01 |
2011-05-23 |
Merck Serono Biodevelopment |
ESTs 5¿PARA PROTEÍNAS SECRETADAS, EXPRESADAS EN DIVERSOS TEJIDOS.
|
CA2297109A1
(en)
*
|
1997-08-01 |
1999-02-11 |
Genset |
5' ests for secreted proteins expressed in muscle and other mesodermal tissues
|
CA2296809A1
(en)
*
|
1997-08-01 |
1999-02-11 |
Genset |
5' ests for secreted proteins identified from brain tissues
|
FR2767135B1
(fr)
|
1997-08-06 |
2002-07-12 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
|
CA2306777A1
(en)
*
|
1997-10-22 |
1999-04-29 |
Helix Research Institute |
Method for screening full-length cdna clones
|
US6548633B1
(en)
|
1998-12-22 |
2003-04-15 |
Genset, S.A. |
Complementary DNA's encoding proteins with signal peptides
|
WO1999040189A2
(en)
*
|
1998-02-09 |
1999-08-12 |
Genset |
Cdnas encoding secreted proteins
|
EP1029045A2
(de)
*
|
1997-11-13 |
2000-08-23 |
Genset |
VERLÄNGERTE cDNAs, DIE FÜR SEKRETIERTE PROTIEINE KODIEREN
|
EP1903111A3
(de)
*
|
1997-11-13 |
2008-07-02 |
Serono Genetics Institute S.A. |
Erweiterte cDNA für sekretierte Proteine
|
US6573068B1
(en)
|
1997-11-13 |
2003-06-03 |
Genset, S. A. |
Claudin-50 protein
|
US20060286639A1
(en)
*
|
1997-11-13 |
2006-12-21 |
Serono Genetics Institute S.A. |
Complementary DNAs encoding proteins with signal peptides
|
ATE440951T1
(de)
*
|
1997-12-17 |
2009-09-15 |
Serono Genetics Inst Sa |
Verlängerte cdns, die für sekretierte proteine kodieren
|
US7223727B2
(en)
|
1998-04-09 |
2007-05-29 |
Serono Genetics Institute S.A. |
GSSP4 polynucleotides and polypeptides and uses thereof
|
US6783961B1
(en)
|
1999-02-26 |
2004-08-31 |
Genset S.A. |
Expressed sequence tags and encoded human proteins
|
JP2002511259A
(ja)
|
1998-04-09 |
2002-04-16 |
ジェンセット |
5’estおよびコードされるヒトタンパク質
|
ATE397064T1
(de)
|
1998-11-04 |
2008-06-15 |
Serono Genetics Inst Sa |
Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
|
US6455280B1
(en)
|
1998-12-22 |
2002-09-24 |
Genset S.A. |
Methods and compositions for inhibiting neoplastic cell growth
|
ES2323445T3
(es)
|
1999-02-10 |
2009-07-16 |
Serono Genetics Institute S.A. |
Marcadores polimorficos del gen lsr.
|
EP1586645A3
(de)
|
1999-02-25 |
2006-02-22 |
Ceres Incorporated |
DNA-Fragmente mit bestimmter Sequenz und die dadurch kodierte Polypeptide
|
EP1163357A4
(de)
*
|
1999-03-19 |
2004-11-10 |
Inst Genetics Llc |
PRIMER-GEBUNDENE VEKTOREN-VERLäNGERUNG (PAVE): EINE AUF DAS 5'-ENDE GERICHTETE CDNS KLONIERUNGSSTRATEGIE
|
JP2002539784A
(ja)
*
|
1999-03-19 |
2002-11-26 |
インヴィトロゲン・コーポレーション |
大腸菌トポイソメラーゼiii及びその相同体を使用して全長核酸配列を得る方法
|
US7485715B2
(en)
|
1999-06-18 |
2009-02-03 |
Ceres, Inc. |
Sequence-determined DNA encoding AP2 domain polypeptides
|
US7479555B2
(en)
|
1999-07-21 |
2009-01-20 |
Ceres, Inc. |
Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
|
CA2311201A1
(en)
*
|
1999-08-05 |
2001-02-05 |
Genset S.A. |
Ests and encoded human proteins
|
US20020058617A1
(en)
|
2000-01-14 |
2002-05-16 |
Joachim Fruebis |
OBG3 globular head and uses thereof for decreasing body mass
|
US6566332B2
(en)
|
2000-01-14 |
2003-05-20 |
Genset S.A. |
OBG3 globular head and uses thereof for decreasing body mass
|
US6989367B2
(en)
|
2000-01-14 |
2006-01-24 |
Genset S.A. |
OBG3 globular head and uses thereof
|
US7338787B2
(en)
|
2000-01-14 |
2008-03-04 |
Serono Genetics Institute S.A. |
Nucleic acids encoding OBG3 globular head and uses thereof
|
EP1261724A4
(de)
|
2000-02-25 |
2004-08-18 |
Invitrogen Corp |
Topoisomerase linker-vermittelte amplifizierungsverfahren
|
US6387624B1
(en)
*
|
2000-04-14 |
2002-05-14 |
Incyte Pharmaceuticals, Inc. |
Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
WO2002016594A2
(en)
|
2000-08-21 |
2002-02-28 |
Invitrogen Corporation |
Methods and reagents for molecular cloning
|
US6875907B2
(en)
|
2000-09-13 |
2005-04-05 |
Pioneer Hi-Bred International, Inc. |
Antimicrobial peptides and methods of use
|
US20060008817A1
(en)
|
2000-12-08 |
2006-01-12 |
Invitrogen Corporation |
Methods and compositions for generating recombinant nucleic acid molecules
|
NZ526194A
(en)
|
2000-12-08 |
2004-10-29 |
Invitrogen Corp |
Methods of covalently linking, in one or both strands, two or more double stranded nucleotide sequences using one or more topoisomerases
|
MXPA04002817A
(es)
|
2001-09-27 |
2004-07-05 |
Pioneer Hi Bred Int |
Polinucleotidos de fitato y metodos de uso.
|
WO2003087313A2
(en)
|
2002-04-08 |
2003-10-23 |
Pioneer Hi-Bred International, Inc. |
Enhanced silk exsertion under stress
|
AU2003238702A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Kabushiki Kaisha Dnaform |
Method of utilizing the 5'end of transcribed nucleic acid regions for cloning and analysis
|
JP4517114B2
(ja)
*
|
2003-03-28 |
2010-08-04 |
国立障害者リハビリテーションセンター総長 |
cDNA合成方法
|
EP1697534B1
(de)
|
2003-12-01 |
2010-06-02 |
Life Technologies Corporation |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
GB0417887D0
(en)
|
2004-08-11 |
2004-09-15 |
Ares Trading Sa |
Protein
|
US8206924B2
(en)
*
|
2006-09-11 |
2012-06-26 |
Osaka University |
Trace mRNA amplification method and use thereof
|
CN101932712B
(zh)
|
2007-11-20 |
2014-05-14 |
先锋国际良种公司 |
用于改善植物应激耐性的玉米乙烯信号转导基因及其调节
|
US20100035249A1
(en)
*
|
2008-08-05 |
2010-02-11 |
Kabushiki Kaisha Dnaform |
Rna sequencing and analysis using solid support
|
WO2010101818A1
(en)
|
2009-03-02 |
2010-09-10 |
Pioneer Hi-Bred International, Inc. |
Nac transcriptional activators involved in abiotic stress tolerance
|
WO2011017492A2
(en)
|
2009-08-05 |
2011-02-10 |
Pioneer Hi-Bred International, Inc. |
Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
CN104531812A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
RU2707251C2
(ru)
|
2011-10-03 |
2019-11-25 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
CN103906835A
(zh)
|
2011-10-25 |
2014-07-02 |
先锋国际良种公司 |
改变植物细胞壁组成以改善生物燃料生产和青贮饲料可消化性的方法
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
EP2833892A4
(de)
|
2012-04-02 |
2016-07-20 |
Moderna Therapeutics Inc |
Modifizierte polynukleotide zur herstellung von in der onkologie nützlichen proteinen und peptiden
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
EP2684954A1
(de)
|
2012-07-10 |
2014-01-15 |
Lexogen GmbH |
5'-schutzabhängige Verstärkung
|
US9422602B2
(en)
*
|
2012-08-15 |
2016-08-23 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for determining nucleic acid degradation
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
WO2014152027A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Manufacturing methods for production of rna transcripts
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
WO2014144767A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
WO2014152030A1
(en)
|
2013-03-15 |
2014-09-25 |
Moderna Therapeutics, Inc. |
Removal of dna fragments in mrna production process
|
US11377470B2
(en)
|
2013-03-15 |
2022-07-05 |
Modernatx, Inc. |
Ribonucleic acid purification
|
BR112015023703A2
(pt)
|
2013-03-15 |
2017-07-18 |
Pioneer Hi Bred Int |
modulação de expressão de deaminase de acc
|
EP3971287A1
(de)
|
2013-07-11 |
2022-03-23 |
ModernaTX, Inc. |
Zusammensetzungen mit synthetischen polynukleotiden zur codierung von crispr-verwandten proteinen und synthetischen sgrnas und verfahren zur verwendung
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
WO2015051169A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
US10323076B2
(en)
|
2013-10-03 |
2019-06-18 |
Modernatx, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
US11479766B2
(en)
*
|
2013-12-05 |
2022-10-25 |
New England Biolabs, Inc. |
Methods for labeling a population of RNA molecules
|
AU2015289656A1
(en)
|
2014-07-16 |
2017-02-16 |
Modernatx, Inc. |
Circular polynucleotides
|
WO2017049286A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a morpholino linker
|
ES2914225T3
(es)
|
2015-10-16 |
2022-06-08 |
Modernatx Inc |
Análogos de cap de ARNm con enlace de fosfato modificado
|
US11866754B2
(en)
|
2015-10-16 |
2024-01-09 |
Modernatx, Inc. |
Trinucleotide mRNA cap analogs
|
EP3409773B1
(de)
|
2016-01-27 |
2020-07-29 |
Kabushiki Kaisha DNAFORM |
Verfahren zur decodierung einer basensequenz von nukleinsäuren entsprechend einer terminalen rns-region und verfahren zur analyse eines dns-elements
|
CN109937253B
(zh)
|
2016-09-14 |
2023-06-30 |
摩登纳特斯有限公司 |
高纯度rna组合物及其制备方法
|
WO2019036683A1
(en)
|
2017-08-18 |
2019-02-21 |
Modernatx, Inc. |
ANALYTICAL METHODS BY HPLC
|
MA49922A
(fr)
|
2017-08-18 |
2021-06-02 |
Modernatx Inc |
Procédés pour analyse par clhp
|
WO2023127774A1
(ja)
*
|
2021-12-28 |
2023-07-06 |
株式会社ダナフォーム |
遺伝子包含体の検出方法及び検出用キット
|
WO2023237703A1
(en)
|
2022-06-09 |
2023-12-14 |
Vestlandets Innovasjonsselskap As |
Method of characterizing capped rna
|